The aim of this study is to find out whether a drug works and is safe to take. The study drug will be compared with a placebo – which looks exactly like the study drug but contains no active medication. Approximately 200 people across Europe, North America and Asia are expected to take part.
Once enrolled, you will receive either the study drug or placebo. You will have a 50% chance of receiving the study drug. Neither you nor the study team will know which medication you are taking. This ensures that the results from the tests are handled in the same way.
Both the study drug and placebo are given as an intravenous infusion. A small tube attached to a needle will deliver a slow ‘drip’ of medication into a vein in your arm. You will receive 8 infusions. Each infusion will last about 1 hour. There will be no charge for any study-related treatment or care.
The study could last up to 10 months. It is composed of 3 parts:
Part 1: Screening – you will undergo tests to see whether you can take part
Part 2: Treatment – if you qualify, you will visit the clinic 10 times; once per month
Part 3: Follow-up – the study team will call you every 6 weeks to check on your health
No drugs are completely safe. One of the aims of this study is to find out whether the drug causes side effects. If you experience any discomfort during the study, you can contact the study team at any time.